BIO-RAD LABORATORIES, INC. Foreign Currency Transaction Gain (Loss), Realized
BIO-RAD LABORATORIES, INC. (BIO.B) reported Foreign Currency Transaction Gain (Loss), Realized of $10.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2026-08-04
- BIO-RAD LABORATORIES, INC. foreign currency transaction gain (loss), realized for the quarter ending 2026-06-30 was $4.30M.
- BIO-RAD LABORATORIES, INC. foreign currency transaction gain (loss), realized for the quarter ending 2026-03-31 was $5.90M.
- BIO-RAD LABORATORIES, INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-12-31 was $86.60M.
- BIO-RAD LABORATORIES, INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-09-30 was $1.60M.
- BIO-RAD LABORATORIES, INC. foreign currency transaction gain (loss), realized for fiscal 2025 was $43.50M.
- BIO-RAD LABORATORIES, INC. foreign currency transaction gain (loss), realized for fiscal 2024 was -$20.70M, a 309.09% decline from fiscal 2023.
- BIO-RAD LABORATORIES, INC. foreign currency transaction gain (loss), realized for fiscal 2023 was $9.90M.
- BIO-RAD LABORATORIES, INC. foreign currency transaction gain (loss), realized for fiscal 2022 was -$19.90M.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.20M 10-Q · filed 2026-08-04 | $96.80M derived: sum of 3 quarters · filed 2026-08-04 | $98.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $5.90M 10-Q · filed 2026-04-30 | $92.50M derived: sum of 2 quarters · filed 2026-04-30 | $94.10M derived: sum of 3 quarters · filed 2026-04-30 | $63.80M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-12-31 | $86.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $88.20M derived: sum of 2 quarters · filed 2026-02-13 | $57.90M derived: sum of 3 quarters · filed 2026-02-13 | $43.50M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$28.70M derived: sum of 2 quarters · filed 2025-10-29 | -$43.10M 10-Q · filed 2025-10-29 | -$60.70M derived: sum of 4 quarters · filed 2025-10-29 |
| 2025-06-30 | -$30.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$44.70M 10-Q · filed 2025-07-31 | -$62.30M derived: sum of 3 quarters · filed 2025-07-31 | -$75.10M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | -$14.40M 10-Q · filed 2025-05-01 | -$32.00M derived: sum of 2 quarters · filed 2025-05-01 | -$44.80M derived: sum of 3 quarters · filed 2025-05-01 | -$42.50M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | -$17.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$30.40M derived: sum of 2 quarters · filed 2025-02-14 | -$28.10M derived: sum of 3 quarters · filed 2025-02-14 | -$20.70M 10-K · filed 2025-02-14 |
| 2024-09-30 | -$12.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$10.50M derived: sum of 2 quarters · filed 2024-10-31 | -$3.10M 10-Q · filed 2024-10-31 | $3.60M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $9.70M 10-Q · filed 2024-08-02 | $16.40M derived: sum of 3 quarters · filed 2024-08-02 | $25.90M derived: sum of 4 quarters · filed 2024-08-02 |
| 2024-03-31 | $7.40M 10-Q · filed 2024-05-08 | $14.10M derived: sum of 2 quarters · filed 2024-05-08 | $23.60M derived: sum of 3 quarters · filed 2024-05-08 | $21.40M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $16.20M derived: sum of 2 quarters · filed 2024-02-16 | $14.00M derived: sum of 3 quarters · filed 2024-02-16 | $9.90M 10-K · filed 2024-02-16 |
| 2023-09-30 | $9.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $7.30M derived: sum of 2 quarters · filed 2023-10-27 | $3.20M 10-Q · filed 2023-10-27 | -$63.10M derived: sum of 4 quarters · filed 2023-10-27 |
| 2023-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$6.30M 10-Q · filed 2023-08-04 | -$72.60M derived: sum of 3 quarters · filed 2023-08-04 | -$53.00M derived: sum of 4 quarters · filed 2023-08-04 |
| 2023-03-31 | -$4.10M 10-Q · filed 2023-05-05 | -$70.40M derived: sum of 2 quarters · filed 2023-05-05 | -$50.80M derived: sum of 3 quarters · filed 2023-05-05 | |
| 2022-12-31 | -$66.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$46.70M derived: sum of 2 quarters · filed 2023-02-17 | -$19.90M 10-K · filed 2023-02-17 | |
| 2022-09-30 | $19.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $46.40M 10-Q · filed 2022-10-28 | ||
| 2022-06-30 | $26.80M 10-Q · filed 2022-07-29 |